Showing posts with label Treatment for infections. Show all posts
Showing posts with label Treatment for infections. Show all posts

Monday, April 8, 2013

Kansas Lawmakers OK Repeal of AIDS Quarantines Ban


TOPEKA, Kan. (AP) — Kansas legislators have approved a bill to protect medical and
emergency workers that also repeals a 25-year-old ban on quarantining AIDS and HIV patients.
The bill is headed to Gov. Sam Brownback after both chambers approved it Friday night. The votes were 36-2 in the Senate and 120-0 in the House.
The bill directs the state health department to draft rules making it easier for medical and emergency workers to learn if they've been exposed to infectious diseases.
The provision repealing the 1988 law protecting AIDS and HIV patients faced strong criticism from gay rights advocates and civil libertarians.
The health department promised legislators its new rules would continue a ban. Agency officials said even without a ban, it would never be medically necessary to quarantine AIDS or HIV patients.

Saturday, March 9, 2013

ABC News very skeptical of the purported "cure" of "HIV positive" infant

ABCNews.com 
Experts Question So-Called HIV 'Cure'
I have copied the text below so I could highlight, in BLUE, some of it, containing the most skeptical phrases and paragraphs.  This piece stood out to me, because it asked a lot of the right questions, particularly about whether the physician had anything resembling "informed consent" to administer the toxic chemo  to a one-day-old child, including high doses of three drugs, with AZT and a "double dose" of nevirapine. The physician practically admits she did not have informed consent.

The questions finally being raised in the aftermath of all the media hype demonstrate the dangers of science-by-press-release.  No peer-reviewed paper was published, and I am not sure one is even being prepared. So a laundry list of questions remains about the methodology, as well as the facts.

Here's my highlighted version of the ABC article:

HIV baby Rico goes home in Minnesota, but fight goes on




Battle between his parents and Mower County over custody and supervision of care is far from over.
After spending the past seven weeks in a hospital crib connected to a feeding tube and powerful drugs to treat his HIV infection, 3-month-old Rico Martinez Nagel finally went home Friday.


But the legal battle between his parents and a southern Minnesota county over custody of the boy and supervision of his medical care is far from over.

Sunday, March 3, 2013

HIV Baby cure, read the fine print

 the "HIV baby cure" story is REALLY BIG
The claim by "scientists" of an "HIV cure" in a baby, which broke Sunday afternoon at the...
Conference on Retroviruses and Opportunistic Infections in Atlanta.
...is VERY BIG.

The "study" is to be released tomorrow at the conference. The entire HIV-AIDS Industry public relations apparatus is hyping the hell out of this.  You can bet it will be front page and TV network news Monday.  I have checked the stories that started appearing early Sunday evening at major media web sites, like the New York Times and CNN
 
They are not just reprinting Associated press or Reuters stories.  These are being written by the health reporters for each paper and network and magazine.  

You can be assured that this "cure" will be used to hype universal testing and "test and treat," not just for infants but for all age groups.  If you check the stock prices for the ARV pharmaceutical companies Monday, I expect you may find heavy spikes for chemo purveyors like Gilead Sciences.

Read the stories carefully.  The baby's doctor started giving the child the poison 30 hours after birth, in high doses, after the mother tested "positive" at the time of birth and BEFORE the baby had even been tested!  The drugs were continued for months, and then the mother stopped bringing the baby to the clinic. Children and family services apparently tracked her down to force the drugs on her child, at which time more tests were done and the apparent miracle was realized--that the baby no longer "had the virus" even months after 
"treatment" had stopped.  (That's my quick take on what is being claimed; read the stories carefully for your selves.)

This is taking the madness to an all new level.  The "cure" of the "Berlin patient" was claimed to be the result of a radical and ultra expensive bone marrow transplant--not ARV's--and thus could not be claimed as a procedure that could be widely used.  This "cure" is all about the drugs!
--Terry Michael


Claimed "HIV CURE" will subject mothers and babies to AZT poisoning

Claims of a baby being "cured" of "HIV" are all over the mainstream media today, This example from the Huffington Post:
 ..with these two paragraphs:

Specialists say Sunday's announcement, at a major AIDS meeting in Atlanta, offers promising clues for efforts to eliminate HIV infection in children, especially in AIDS-plagued African countries where too many babies are born with the virus.
"You could call this about as close to a cure, if not a cure, that we've seen," Dr. Anthony Fauci of the National Institutes of Health, who is familiar with the findings, told The Associated Press.
A doctor gave this baby faster and stronger treatment than is usual, starting a three-drug infusion within 30 hours of birth. That was before tests confirmed the infant was infected and not just at risk from a mother whose HIV wasn't diagnosed until she was in labor.
It is just outrageous to claim that an infant is carrying an pathogen, based on an antibody blood test given at birth--when it is just fact that pregnant mothers pass antibodies from their bloodstreams, through the placenta, and to the fetus. 

This is another attempt to claim efficacy of highly toxic chemotherapy, which endangers child health rather than protects it. This "HIV cure" will doubtless be used by child "authorities" to subject mothers and babies to AZT and other "anti-retroviral" poison.

--Terry Michael

Breast Milk Kills HIV and Blocks Its Oral Transmission in Humanized Mouse

sciencedaily.com
More than 15 percent of new HIV infections occur in children. Without treatment, only 65 percent of HIV-infected children will live until their first birthday, and fewer than half will make it to the age of two. Although breastfeeding is attributed to a significant number of these infections, most breastfed infants are not infected with HIV, despite prolonged and repeated exposure.

Saturday, December 1, 2012

Will a so-called "functional" cure be enough to keep HIV in check

 - www.theatlantic.com
As scientists and advocates push beyond merely managing HIV infection with expensive and toxic prescription medications, an overarching question is: Will a so-called "functional" cure be enough to keep HIV in check, such that people with the virus can go months between medical treatments? Or is a truly "sterilizing" cure -- a complete and provable eradication of all traces of HIV -- the only goal worth pursuing?

Saturday, November 17, 2012

Gilead Presents Encouraging Data - HIV therapy Stribild

FOLLOW THE MONEY

Posted
11/16/2012 1:00 PM
 by Zacks Equity Research


Gilead Sciences(GILD) recently presented encouraging long-term data on its HIV therapy Stribild from two ongoing phase III studies (102 and 103) as a first-line therapy. Data from study 102 revealed that Stribild was non-inferior to Gilead's Atripla after two years of treatment.

Data from study 103 demonstrated the non inferiority of Stribild to Norvir (ritonavir)-boosted Reyataz plus Truvada after a similar time period. While Norvir is marketed byAbbott Labs(ABT), Reyataz is marketed byBristol-Myers Squibb(BMY). Gilead presented the encouraging results at the 11th international congress on drug therapy regarding HIV infection in the UK.

We note that Stribild, a combination pill, is a new addition to Gilead's formidable HIV franchise. The drug was approved by the US Food and Drug Administration (FDA) in August 2012 as a first-line therapy for treating adults suffering from HIV. The approval was based on encouraging 48 weeks data from studies 102 and 103. Stribild is under review for the same indication in the EU.

Neutral on Gilead

We currently have a Neutral recommendation on Gilead. The stock carries a Zacks #3 Rank (Holdrating) in the short run. We remain optimistic on the growth prospects of Gilead's HIV drugs, Truvada and Atripla. We are also encouraged by the sales ramp of Complera/Eviplera, which together with Stribild, has further fortified the HIV franchise and helped to mitigate the impact of upcoming patent expirations.

Gilead is looking to combat the threat of genericization by inking deals, making acquisitions and introducing new products. To further strengthen its hepatitis C virusportfolio, Gilead purchased Pharmasset earlier in the year, for approximately $11.1 billion.

Monday, November 12, 2012

Joseph Sonnabend, Remembering the Original AZT Trial

An interesting article by early AIDS doctor Joseph Sonnabend, who can’t usually decide what side he’s on, but enough time has passed that he now thinks it is okay to be against AZT.
reposted from http://www.aras.ab.ca/

By Joseph Sonnabend - blogs.poz.com


From time to time I'll write about some of the earliest events in the epidemic.  I've had the opportunity to participate in some of them, both as a physician caring for people with AIDS from its first recognition in 1981 and also as a microbiologist.   Today, I'm going back 24 years to recall - with the help of a few contemporary documents, a significant event in the history of the HIV/AIDS epidemic.  This was the introduction of AZT, the first drug to be approved for the treatment of HIV infection.
This is not so much about AZT as it is about the trial that led to its approval and how it made me aware that even if we then had no lifesaving treatments there was much we were able to do for our patients.
I'm certainly not writing a history of the introduction of AZT. This is just the personal account of a doctor treating HIV infected individuals at the time, who was unable to recommend AZT for his patients at least not at the huge dose then suggested by authorities who had taken on the medical leadership of the epidemic.

I'm not sure that it's even possible to adequately describe the terror and desperation felt in the early 1980s.   By 1986 nothing of any use regarding treatments had come from the Public Health Service and very little from the academic medical community.  For example, people with AIDS had to wait until 1989 for the CDC to issue guidelines for the prevention ofpneumocystis pneumonia, the most frequent cause of death among them, while this type of pneumonia had often been routinely prevented in many other individuals who were also at risk because they were recipients of kidney transplants, or were children with leukemia.  The way to prevent pneumocystis pneumonia was no secret - it had been published in 1977.  


Sunday, November 4, 2012

Here are ten facts every person diagnosed as HIV-positive has a right to know


reposted from helpforhiv.com/
Being diagnosed HIV-Positive can be a traumatic experience – emotionally, mentally, and physically.
Following the initial shock, most people are faced with a lot of fears and questions about a number of life-changing issues.
We created this website to help you find your way through these fears by helping you better understand the medical facts about your diagnosis, and to provide information that can help guide you in making some important decisions.
Here are ten facts every person diagnosed as HIV-positive has a right to know (click on the words in green for quick references)…
FACT #1: There is strong evidence that the HIV test you took is very often wrong. We have found over fifty different scientific studies listing seventy non-HIV conditions that can make the test produce false positive results. Depending on which test you took, they have been proven to be wrong as much as 90% of the time. So you might not be HIV-positive at all.

Tuesday, October 16, 2012

HIV testing cannot detect "HIV" itself



Since HIV testing cannot detect "HIV" itself, and since the test kits currently used to diagnose alleged "HIV infection" only rely on surrogate markers such as antibodies or genetic material, a study should exist somewhere in the published medical literature which shows that at least one type of surrogate test for HIV has been validated for accuracy by the direct isolation of HIV itself from people who test antibody, RNA , or DNA positive.

A study that validates HIV test kits is missing from the medical literature and It has been almost 30 years since the alleged discovery of HIV and the development and marketing of the HIV antibody test kits, yet it appears that no study ever validated HIV tests by the direct purification of HIV from persons who test positive or have a "viral load."

Wednesday, October 3, 2012

Risk Reduction and HIV Testing Messages Sent Through Social Networking Media Can Be Effective

Sean Young, PhD, MS Department of Family Medicine UCLA

This is part of an internal email mailed to a Gay Youth group:


...The machine is part of a small ‘pilot’ research study being conducted by a UCLA researcher named Sean Young (at the UCLA Center for HIV Intervention, Prevention, and Treatment Services). Pilots are small projects that are designed to establish the feasibility of answering a specific research question. If the results are promising, then the investigator can apply for funding for a full scale study.
 
This particular study is designed to assess whether risk reduction and HIV testing messages sent through social networking media can be effective in motivating someone to obtain an HIV home test kit from a vending machine. So the study is looking at both social network ‘diffusion’ of risk reduction information as well as acceptability of use of vending machines to obtain test kits.


Monday, October 1, 2012

Fears over Aids 'miracle pill": Truvada

MARIKA HILL at www.stuff.co.nz
Fears are being raised that a ''magic pill'' could spark a new wave of the Aids epidemic in Auckland.
The HIV treatment drug Truvada is being touted as a way to protect against infection in the United States and local AIDs campaigners fear this false promise will lead to complacency about safe sex.

Monday, September 3, 2012

Sean Strub, Poz magazine, challenges Julio Montaner,Director of the British Columbia Centre for Excellence in HIV/AIDS, on AIDS "treatment as prevention"

POZ magazine founder Sean Strub, on Julio Montaner and so-called "treatment as prevention," XIX Intnl AIDS Conf., Washington, July 23, 2012. Strub believes in single pathogen theory, but leads against "over use" of chemo "anti-retrovirals," opposing "test-and treat" and "PrEP" or "pre-exposure prophylaxis." Montaner has fed toxic ARV's to Vancouver IV drug users for years--immune suppressive poison to people already pumping poison into their veins. Includes Montaner's weasel word response. Video from Kaiser foundation. (3-second drop-out at point 1:43 into video.)

  • We are not about mandatory anything but testing!
  • Yes, mandatory testing to capture more "postives" and then destroy their health with immediate poisoning with highly toxic chemotherapy. Universal testing is The HIV-AIDS Industry's government's and non-profits' collusion with Gilead Sciences and the other BigPharma producers of the poison.

Sunday, August 12, 2012

Everyone Reacts Positive on the ELISA Tests for HIV

by roberto giraldo


For the last 6 years I have been working at a laboratory of clinical immunology in one of the most prestigious University Hospitals in the City of New York. Here I have had the opportunity to personally run and get to know in detail the current tests used for the diagnosis of HIV status, namely, the ELISA, Western blot and Viral Load tests.



1. Diluting the serum for the ELISA testThe ELISA test is a test for antibodies against what is supposed to be the Human Immunodeficiency Virus or HIV. To run this test, an individual’s serum has to be diluted to a ratio of 1:400 with a special specimen diluent. According to the test kit manufacturer this diluent contains "0.1% triton X-100, Bovine and Goat Sera (minimum concentration of 5%) and Human T-Lymphocyte Lysate (minimum titer 1:7500). Preservative: 0.1% Sodium Azide" (1).

This extraordinarily high dilution of the person’s serum [400 times] took me by surprise. Most serologic tests that look for the presence of antibodies against germs uses neat serum [undiluted]. For example, the tests that look for antibodies to hepatitis A and B viruses, rubella virus, syphilis, hystoplasma and cryptococus, to mention a few of them, use straight serum [undiluted]. However, to try to prevent false positive reactions some serologic tests use diluted serum; for example this is the case with tests that look for antibodies to measles, varicella and mumps viruses which use a dilution of 1:16, to cytomegalovirus [CMV] 1:20 and to Epstein-Barr Virus [EBV] 1:10.

The obvious questions are: What makes HIV so unique that the test serum needs to be diluted 400 times? And what would happen if the individual’s serum is not diluted ?


2. Testing the ELISA test without diluting the serum

Tuesday, July 17, 2012

WHAT HIV DRUGS DO

by Henry Bauer

The previous post (OFFICIAL GUIDELINES FOR HIV TREATMENT, 14 December 2007) offered some extracts from the text of the official Guidelines for treating “HIV-1 infected” people, even when they don’t feel ill and are not visibly ill. The Guidelines also have detailed Tables listing the frequent and serious “side” effects of antiretroviral drugs.
The scare quotes are around “side” to emphasize how evasive a euphemism this is. Molecules, chemicals, drugs can’t choose to do only what we want them to do. Any foreign substance disturbs our physiology, which is an intricate system of balances and feedbacks where any one change is likely to induce others as well. The more powerful a molecule, the more likely it is to disrupt our metabolism in multiple ways. Antiretroviral drugs are extremely powerful molecules that can kill cells and block receptors and incapacitate enzymes. As in cancer chemotherapy, antiretroviral treatment kills or disables innocent as well as guilty cells.
All examples in the following are taken from the 1 December 2007 version of the Treatment Guidelines.

Wednesday, July 4, 2012

Predictability of a CD4 Count


Predictability of a CD4 Count

When an AIDS doctor declares that a patient with a CD4 count is “severely immunesuppressed”
he is making a prediction based on the CD4 count with near certainty. When
a doctor proclaims that an HIV positive person’s CD4 count of 200 or 350 or 500 shows
that it is “time to start drugs” they are also making a prediction on the basis of a CD4
count, a prediction with implied certainty. Perhaps, if pressed, the doctor might admit that
there are some people with low CD4 counts who are not sick, but the basic message is
that CD4 counts have been shown, scientifically, to be highly accurate indicators of your
stage of “progression to AIDS” – from asymptomatic to pre-AIDS (“AIDS-related
complex”) to full-blown AIDS and then death.
But, what is the evidence that CD4 counts are associated with stage of immune
suppression? And, how accurate would a prediction that a certain CD4 count indicates
that a person is at a particular stage of HIV or AIDS be?

Thursday, June 28, 2012

D.C. hopes to test 35,000 employees for HIV over 3 months


By  -  

The District’s departments of Health and Human Resources, along with union leaders, kicked off a campaign Wednesday with the goal of testing 35,000 city employees over the next three months. During that period, city employees who decide to get tested will first receive instructions on how to prevent infection. READ the whole article: washingtonpost.com

What they don't tell people is:

What you can expect

By Mayo Clinic staff
HIV is usually diagnosed by testing your blood or a sample of cells taken with a cotton swab from inside your cheek for the presence of antibodies to the virus. Urine samples can also be tested for HIV antibodies, but the results are slightly less accurate.
Unfortunately, these HIV tests aren't accurate immediately after infection because it takes time for your body to produce antibodies to the virus. Most people develop antibodies to the HIV virus within three to six months of infection.
If this test is positive — meaning you have antibodies to HIV — lab technicians run the same test again on the sample you provided. If the repeat test is also positive for HIV antibodies, you need a confirming blood test called the Western blot test, which checks for the presence of HIV proteins.